We welcome the decision by the UK Joint Committee on Vaccination and Immunisation (JCVI) to broaden the eligibility for the vaccination programme for the Shingrix recombinant herpes zoster vaccine ...
The first blood-stage malaria vaccine RH5.1/Matrix-M has the potential to be a component within a developing malaria vaccine strategy, said a report on Thursday.